Sirolimus

Definition

Sirolimus is indicated by the Food and Drug Administration (FDA) to be used after a kidney transplant to prevent the body from rejecting the new kidney. Sirolimus may also have a role in prevention of organ rejection in heart or lung transplantation, and prevention of graft-versus-host disease in patients undergoing bone marrow transplantation. Sirolimus (formerly known as rapamycin) became available at the end of 1999 and is marketed under the brand name Rapamune by Wyeth-Ayerst Laboratories.

Description

Sirolimus belongs to a class of macrolide antibiotics and is isolated from an organism named streptomyces hygriscopicus.

Sirolimus prevents the immune system from attacking the transplanted organ by decreasing the growth of certain chemicals in the body responsible for the immune function (B and T lymphocytes). Sirolimus works differently from other immunosuppressants used to prevent organ rejection after transplantation (azathioprine, mycophenolate mofetil, tacrolimus, cyclosporine, and steroids). It should be given in combination with cyclosporine and steroids to prevent acute rejection of a transplanted kidney. This drug is available as a tablet and a liquid and can be used in children and adults.

Recommended dosage

Adults

KIDNEY TRANSPLANTATION.

The first dose of 3 tablets (2 mg each) or 6 milliliters of oral solution should be given as soon as possible after a kidney is transplanted. Then, a maintenance dose of 2 mg should be given once a day.

Children over 13 years of age and Adults less than 40 kg (88 lbs)

KIDNEY TRANSPLANTATION.

3 mg of sirolimus per square meter of body surface area on day 1 after transplantation, followed by a maintenance dose of 1 mg per square meter per day.

Children less than 13 years of age

Check with a physician.

Administration

Sirolimus should be administered in combination with cyclosporine and steroids. To decrease the risk of side effects, sirolimus should be given four hours after cyclosporine. To avoid variations in blood levels, sirolimus should be taken consistently— either always with food or always without food. Sirolimus oral solution should only be mixed with water or orange juice and consumed immediately. Juices or liquids other than water or orange juice should not be used to mix sirolimus. Bottled sirolimus solution should be stored in the refrigerator, but not frozen. Refrigerated sirolimus solution may develop a slight haze. If haze is noticed, the drug should be left at room temperature and gently shaken until haze disappears. If a dose is missed, it should taken as soon as possible unless it is almost time for the next dose. Two doses at the same time should not be taken.


Advertisement
Advertisement